InvestorsHub Logo
Followers 8
Posts 394
Boards Moderated 0
Alias Born 07/22/2011

Re: None

Monday, 07/22/2019 9:22:49 AM

Monday, July 22, 2019 9:22:49 AM

Post# of 34625
Here are a few highlights from presentation for me so far:

Mr. Hoang says he is very excited, and Multi-TAA has potential to become 1St line SOC.

In Arm A, 6 of 8 patients had tumor shrinkage. One patient who progressed during chemo, reversed on Multi-TAA.

CR quite uncommon-1 in several hundred with current SOC.

Tolerability excellent-more doses (currently 6) may achieve even better response. Also dosage can be increased.

More to come...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News